Composition and state of protein in heart muscle of normal dogs and dogs with experimental myocardial failure

Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy

BACKGROUND

Defects in energetics are thought to be central to the pathophysiology of hypertrophic cardiomyopathy (HCM); yet, the determinants of ATP availability are not known. The purpose of this study is to ascertain the nature and extent of metabolic reprogramming in human HCM, and its potential impact on contractile function.

METHODS

We conducted proteomic and targeted, quantitative metabolomic analyses on heart tissue from patients with HCM and from nonfailing control human hearts.

RESULTS

In the proteomic analysis, the greatest differences observed in HCM samples compared with controls were increased abundances of extracellular matrix and intermediate filament proteins and decreased abundances of muscle creatine kinase and mitochondrial proteins involved in fatty acid oxidation. These differences in protein abundance were coupled with marked reductions in acyl carnitines, byproducts of fatty acid oxidation, in HCM samples. Conversely, the ketone body 3-hydroxybutyrate, branched chain amino acids, and their breakdown products, were all significantly increased in HCM hearts. ATP content, phosphocreatine, nicotinamide adenine dinucleotide and its phosphate derivatives, NADP and NADPH, and acetyl CoA were also severely reduced in HCM compared with control hearts. Functional assays performed on human skinned myocardial fibers demonstrated that the magnitude of observed reduction in ATP content in the HCM samples would be expected to decrease the rate of cross-bridge detachment. Moreover, left atrial size, an indicator of diastolic compliance, was inversely correlated with ATP content in hearts from patients with HCM.

CONCLUSIONS

HCM hearts display profound deficits in nucleotide availability with markedly reduced capacity for fatty acid oxidation and increases in ketone bodies and branched chain amino acids. These results have important therapeutic implications for the future design of metabolic modulators to treat HCM.

ND3 Cys39 in complex I is exposed during mitochondrial respiration

Mammalian complex I can adopt catalytically active (A-) or deactive (D-) states. A defining feature of the reversible transition between these two defined states is thought to be exposure of the ND3 subunit Cys39 residue in the D-state and its occlusion in the A-state. As the catalytic A/D transition is important in health and disease, we set out to quantify it by measuring Cys39 exposure using isotopic labeling and mass spectrometry, in parallel with complex I NADH/CoQ oxidoreductase activity. To our surprise, we found significant Cys39 exposure during NADH/CoQ oxidoreductase activity. Furthermore, this activity was unaffected if Cys39 alkylation occurred during complex I-linked respiration. In contrast, alkylation of catalytically inactive complex I irreversibly blocked the reactivation of NADH/CoQ oxidoreductase activity by NADH. Thus, Cys39 of ND3 is exposed in complex I during mitochondrial respiration, with significant implications for our understanding of the A/D transition and the mechanism of complex I.

Application of UVA-riboflavin crosslinking to enhance the mechanical properties of extracellular matrix derived hydrogels

Hydrogels derived from extracellular matrix (ECM) have become increasing popular in recent years, particularly for use in tissue engineering. One limitation with ECM hydrogels is that they tend to have poor mechanical properties compared to native tissues they are trying to replicate. To address this problem, a UVA (ultraviolet-A) riboflavin crosslinking technique was applied to ECM hydrogels to determine if it could be used to improve their elastic modulus. Hydrogels fabricated from corneal, cardiac and liver ECM were used in this study. The mechanical properties of the hydrogels were characterized using a spherical indentation technique. The microstructure of the hydrogels and the cytotoxic effect of crosslinking on cell seeded hydrogels were also evaluated. The combination of UVA light and riboflavin solution led to a significant increase in elastic modulus from 6.8kPa to 24.7kPa, 1.4kPa to 6.9kPa and 0.9kPa to 1.6kPa for corneal, cardiac and liver ECM hydrogels respectively. The extent of this increase was dependent on a number of factors including the UVA exposure time and the initial hydrogel concentration. There were also a high percentage of viable cells within the cell seeded hydrogels with 94% of cells remaining viable after 90min exposure to UVA light. These results suggest that UVA-riboflavin crosslinking is an effective approach for improving the mechanical properties of ECM hydrogels without resulting in a significant reduction of cell viability.

Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo

In beating hearts, phosphorylation of myosin regulatory light chain (RLC) at a single site to 0.45 mol of phosphate/mol by cardiac myosin light chain kinase (cMLCK) increases Ca(2+) sensitivity of myofilament contraction necessary for normal cardiac performance. Reduction of RLC phosphorylation in conditional cMLCK knock-out mice caused cardiac dilation and loss of cardiac performance by 1 week, as shown by increased left ventricular internal diameter at end-diastole and decreased fractional shortening. Decreased RLC phosphorylation by conventional or conditional cMLCK gene ablation did not affect troponin-I or myosin-binding protein-C phosphorylation in vivo. The extent of RLC phosphorylation was not changed by prolonged infusion of dobutamine or treatment with a β-adrenergic antagonist, suggesting that RLC is constitutively phosphorylated to maintain cardiac performance. Biochemical studies with myofilaments showed that RLC phosphorylation up to 90% was a random process. RLC is slowly dephosphorylated in both noncontracting hearts and isolated cardiac myocytes from adult mice. Electrically paced ventricular trabeculae restored RLC phosphorylation, which was increased to 0.91 mol of phosphate/mol of RLC with inhibition of myosin light chain phosphatase (MLCP). The two RLCs in each myosin appear to be readily available for phosphorylation by a soluble cMLCK, but MLCP activity limits the amount of constitutive RLC phosphorylation. MLCP with its regulatory subunit MYPT2 bound tightly to myofilaments was constitutively phosphorylated in beating hearts at a site that inhibits MLCP activity. Thus, the constitutive RLC phosphorylation is limited physiologically by low cMLCK activity in balance with low MLCP activity.

Regulation of oxidative phosphorylation complex activity: effects of tissue-specific metabolic stress within an allometric series and acute changes in workload

The concentration of mitochondrial oxidative phosphorylation complexes (MOPCs) is tuned to the maximum energy conversion requirements of a given tissue; however, whether the activity of MOPCs is altered in response to acute changes in energy conversion demand is unclear. We hypothesized that MOPCs activity is modulated by tissue metabolic stress to maintain the energy-metabolism homeostasis. Metabolic stress was defined as the observed energy conversion rate/maximum energy conversion rate. The maximum energy conversion rate was assumed to be proportional to the concentration of MOPCs, as determined with optical spectroscopy, gel electrophoresis, and mass spectrometry. The resting metabolic stress of the heart and liver across the range of resting metabolic rates within an allometric series (mouse, rabbit, and pig) was determined from MPOCs content and literature respiratory values. The metabolic stress of the liver was high and nearly constant across the allometric series due to the proportional increase in MOPCs content with resting metabolic rate. In contrast, the MOPCs content of the heart was essentially constant in the allometric series, resulting in an increasing metabolic stress with decreasing animal size. The MOPCs activity was determined in native gels, with an emphasis on Complex V. Extracted MOPCs enzyme activity was proportional to resting metabolic stress across tissues and species. Complex V activity was also shown to be acutely modulated by changes in metabolic stress in the heart, in vivo and in vitro. The modulation of extracted MOPCs activity suggests that persistent posttranslational modifications (PTMs) alter MOPCs activity both chronically and acutely, specifically in the heart. Protein phosphorylation of Complex V was correlated with activity inhibition under several conditions, suggesting that protein phosphorylation may contribute to activity modulation with energy metabolic stress. These data are consistent with the notion that metabolic stress modulates MOPCs activity in the heart.

Studies of actomyosin from cardiac muscle of dogs with experimental congestive heart failure

Comparative studies were made on cardiac actomyosin from normal dogs and from dogs with experimental failure. Actomyosin was characterized by ultracentrifugal sedimentation velocity, viscosity and ATP-ase measurements. The data on actomyosin from normal cardiac muscle showed a striking similarity to the findings reported by others for skeletal muscle actomyosin. The only difference found between cardiac actomyosin front the normal and experimental material was an abnormal component ( S 20 W = 5.0-6.7) in the sedimentation pattern for actomyosin from 4 of 11 dogs with cardiac failure. It seems likely that the changes in actomyosin which resulted in the abnormal sedimentation pattern were produced during extraction or preparation of the actomyosin and that they do not reflect an altered state of actomyosin in the functioning heart. The explanation for the occurrence of this slow sedimentation component solely in the experimental material is not clear.

Properties of myocardium in cardiomegaly

The adult rat's ventricular myocardium is able to increase its mass markedly while maintaining its unit quality. It does so by maintaining constant the design of the sarcomeres: an increase in length is accomplished by the addition of sarcomeres in series; an increase in tension production is accomplished by the addition of more cross-sectional area of a uniform quality. This was shown by the almost constant concentration of the contractile protein, actomyosin, as well as by the histologic evidence of the constancy in the sarcomere lengths. Functional support was obtained by the finding of an identity in the parameters of the length-tension curves; the curves differed only in the absolute magnitude of the tensions, a difference that completely disappeared when suitable corrections were made for the size of the muscle. The electrical parameters also indicated a lack of change in the quality of the excitatory membrane phenomena. However, some data were presented that suggest that the myocardium may show altered properties dependent on the age of the animal. No evidence was found in support of the concept of detrimental consequences at least with this degree of cardiomegaly. It is rather concluded that this degree of cardiomegaly is accomplished without change in the basic architecture, properties, or concentration of the contractile mechanism.

Cardiac myosin and congestive heart failure in the dog

Chronic congestive heart failure has been produced in dogs by surgical induction of valvular disease. Cardiac myosin was isolated from the normal dogs and from dogs with congestive heart failure and characterized. Physicochemical properties of the cardiac myosins were determined by measurements of velocity sedimentation, partial specific volume, rate of diffusion, limiting viscosity number, light-scattering behavior, and ATPase activity. The measurements show that normal cardiac myosin (myosin C) has a molecular weight of 225,000, whereas myosin from the failing heart (myosin F) has a molecular weight of 690,000. This change in molecular weight occurs without a marked alteration in amino acid composition and suggests that end-to-end trimerization of normal cardiac myosin occurs in association with congestive heart failure in the dog. There was no significant change in ATPase activity.

Cardiac contractile proteins. Adenosine triphosphatase activity and physiological function

This review has pointed out the good correlation frequently observed between ATPase activity of various contractile protein preparations and contractile function of various muscles including the myocardium. Some of the variables in the measurement of the various ATPases and the relationship of these measurements to physiological ATPase in the intact myofibril have been mentioned. The possible roles of changes in the light chains of sulfhydryl groups in the control of ATPase activity have been outlined. The possibility that phosphorylating reactions might exert control over physiological activity remains to be clarified. It is evident that, despite the large amount of research that has been done, our understanding of how the biochemistry of contractile proteins relates to physiological function is in its infancy, and only with a more complete elucidation of the underlying biochemistry of the components of contractile proteins of physiological and pathophysiological adaptations become evident.

Activity of the vesicular calcium pump in the spontaneously failing heart-lung preparation

The in vitro calcium uptake activity has been examined in fragments of sarcoplasmic reticulum, i.e. vesicles, obtained from hearts spontaneously failing in the canine heart-lung preparation. The rate of uptake was found to be less than that observed for vesicles from control hearts. If the vesicles were prepared from a failed heart that had been treated in vivo with ouabain, then the rate of calcium uptake was normal. In vitro additions of ouabain increased the rate of calcium uptake only with vesicles prepared from failing hearts. This effect of ouabain on calcium uptake by vesicles appears, therefore, to be specific for the defect causing depression of calcium uptake. No evidence could be found that the depression of calcium uptake is due to uncoupling of the pump adenosine triphosphatase. Calcium uptake and adenosine triphosphatase activity were found to be proportionately depressed in the failing heart and proportionately restored by ouabain.

The Effect of Digoxin on the Intermediary Metabolism of the Heart as Measured by Glucose-C 14 Utilization in the Intact Dog

Administration of a therapeutic dose level of digoxin in the intact dog resulted in an augmentation of the glucose utilization of the myocardium accompanied by a greatly increased rate of glycolytic and oxidative activity. The contribution of glucose to the total metabolism of the heart was increased, and the utilization of noncarbohydrate substrates was decreased. These metabolic changes occurred in the absence of changes in the dynamic functions of the heart, indicating that the metabolic alterations were due to a primary effect of the drug rather than an effect secondary to an altered state of cardiac activity.

Physiologic Changes during Chronic Congestive Heart Failure in Dogs with Tricuspid Insufficiency and Pulmonic Stenosis

chronic congestive heart failure was studied in dogs with surgically-produced tricuspid insufficiency and pulmonic stenosis. Ascites formed in association with an elevation in mean right atrial pressure. The volume of ascitic fluid and the rate of urinary sodium excretion varied greatly in individual dogs during the course of congestive failure and among the different animals. Sodium retention was most common but periods of sodium balance and natriuresis occurred. Comparative data on the right and left ventricles were obtained from determinations of intracardiac pressures, measurements of ventricular muscle mass at the time of sacrifice and studies of the lungs for evidence of chronic passive congestion. There was significant right ventricular hypertrophy but no evidence of left ventricular hypertrophy or failure.

CONTRACTILITY OF ACTOMYOSIN BANDS PREPARED FROM NORMAL AND FAILING HUMAN HEARTS1

Images

Contractile properties of glycerolextracted muscle bundles from the chronically failing canine heart

Chronic congestive heart failure was induced in dogs by the surgical production of tricuspid insufficiency and pulmonary stenosis. Glycerol-extracted trabecular bundles from the right and left ventricles of these dogs developed significantly less tension than did similar preparations from the hearts of normal dogs. The maximum working capacity of the bundles from failing hearts was lower than that of bundles from normal hearts, hut the rate of hydrolysis of adenosinetriphosphate was the same as that of normal heart preparations. Since glycerol-extracted muscle bundles retain the basic contractile properties of fresh, surviving whole muscle but are free from membrane, neurohormonal, ionic and pH effects and are isolated from energy-supplying systems of muscle, defective contractility and decreased working capacity of muscle bundles from failing hearts may be appropriately ascribed to physiochemical changes in the contractile protein, actomyosin. Such alterations are undoubtedly of structural significance, and are related to the conformation changes in actomyosin which characterize the contractile cycle of muscle.